Viewing nowCandesartan Tablets 16 mg (Candesartan Cilexetil)
Candesartan Cilexetil 16mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201905791 · Approved 2019.08.14 · Insurance code 657307780
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
This medication is used for controlling blood pressure in patients with essential hypertension. It is also suitable for severe heart failure patients whose left ventricular function is impaired and who need additional treatment with ACE inhibitors or have difficulty using ACE inhibitors. This efficacy helps stabilize blood pressure and improve heart function.
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, another treatment should be considered. The maximum effect is reached within 4 weeks after starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
1. Essential hypertension: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This drug should not be used in patients with certain allergic reactions, severe liver disease or cholestasis, hereditary angioedema, or specific genetic disorders. Special caution is required for elderly patients, those with poor kidney function, patients with hyperkalemia, and those with heart valve diseases when using this medication. During treatment, side effects such as dizziness, back pain, and respiratory infections may occur, and in some patients, serious blood abnormalities or liver function abnormalities may develop, so if any abnormal symptoms appear, medical consultation should be sought immediately. Due to the risk of decreased kidney function, hyperkalemia, hypotension, etc., regular blood tests and kidney function tests are necessary, and particular caution is required for heart failure patients or kidney transplant patients. The blood pressure-lowering effect may increase when taking this medication in combination with other antihypertensive agents or certain diuretics, so it is essential to inform the healthcare provider about any other medications being taken. Pregnant or breastfeeding women should avoid using this medication; if unavoidable, breastfeeding should be stopped. Safety and effectiveness have not been established in children and adolescents, so use is not recommended in this age group. In case of overdose, symptoms such as hypotension and dizziness may occur, and emergency treatment should be sought immediately, as this medication is not removed by dialysis. This medication should be kept out of the reach of children, and transferring it to another container should be avoided as it is detrimental to quality preservation. Caution should be exercised when driving or operating machinery, as dizziness may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius. This helps maintain the medication’s effectiveness for a longer period.
Light yellow-pink round tablets with both sides convex
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCandesartan Cilexetil 16mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Yuhans Chemical Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Yuhan Corporation

Candesartan Cilexetil 32mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Jong Kun Dang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.